A cladistic analysis was carried out to identify haplotypes hypothesized to differ for functional DNA sequence variations within the apolipoprotein (apo) AI-CIII-AIV gene cluster that affect plasma lipid, lipoprotein and apolipoprotein levels. A sample of unrelated healthy French Canadians was studied. First, a cladogram of the observed apo AI-CIII-AIV haplotypes was estimated. Then this cladogram was used to define a statistical analysis of the association between haplotype variation and variation in plasma lipid, lipoprotein and apolipoprotein levels. Three haplotypes were identified which were associated with small (5-12% of the total sum of squares) pleiotropic effects on plasma lipid, lipoprotein and apolipoprotein traits and these effects were context, i.e. gender, dependent.
INTRODUCTION
One of the objectives of human quantitative genetics is to characterize the DNA sequence variations that influence interindividual phenotypic differences in traits that are continuously distributed in the population a t large. The first step in accomplishing this is to identify haplotypes which differ for these functional sequence variations. This study is aimed at identifying such haplotypes associated with interindividual variation in quantitative traits known to contribute to the risk of developing coronary artery disease (CAI)). We present here a cladistic analysis (Templeton et al. 1987 (Templeton et al. , 1992 Sing et al. 1992; Haviland, 1993; Templeton & Sing, 1993) to identify haplotypes hypothesized to have DNA sequence differences, within the apolipoprotein (apo) AI-CIII-AIV gene cluster, which have relatively small effects on plasma lipid, lipoprotein and apolipoprotein levels.
We begin with a justification for the use of a cladistic analysis for identifying haplotypes that differ for functional interindividual DNA sequence variations in a gene hypothesized to be involved in the genetic architecture of a quantitative trait. Genetic architecture is defined by the number of genes involved in the metabolism of the trait, the number of alleles at each gene and their relative frequencies, the arrangement of these alleles into genotypes, the impact of each of the alleles, single locus genotypes and multilocus genotypes on intra-and interindividual trait variation and the impact of each of these alleles and genotypes on the relationships between the trait and other traits (Boerwinkle et al. 1986; Sing et al. 1992a, b) . There are two general approaches taken when studying the genetic architecture of continuously distributed risk factor traits: the top-down and the bottom-up approaches (reviewed by Sing et al. 1985 Sing et al. , 1988 ; Sing & Moll, 1990) . The top-down approach involves estimating the impact of the effects of unmeasured genetic and environmental factors on trait variation among individuals in the population at large using genealogical relationships (biometrical top-down approach) or characterizing the genotypes associated with specific trait values (molecular top-down approach). The biometrical top-down approach estimates the genetic component of trait variation but cannot be used to address questions about the location of functional sequence variations (reviewed by MacCluer, 1992 ; Moll, 1993) . The molecular top-down approach involves selecting individuals a t the tails of the trait distribution, e.g. individuals with very high and very low plasma cholesterol levels, with the ultimate aim of comparing their DNA sequences to determine sequence differences that may be responsible for the extreme phenotypes. The molecular top-down approach has been successful in identifying rare mutations with large effects (e.g. Goldstein & Brown, 1989) , but has contributed little to our understanding of the genetic architecture of a quantitative trait in the population at large. The molecular top-down approach, which uses samples of individuals from the tails of a trait distribution, gives no information about the penetrance functions (i.e. distribution of phenotypes in the population at large) associated with each of the many functional interindividual DNA sequence variations that are involved in the genetic architecture of a trait (see for example, Hobbs et al. 1989 ; Roy et al. in press) . Also, identifying the specific DNA sequence variations with a functional effect is not a trivial problem (e.g. Choudhary & Laurie, 1991;  Laurie et al. 1991) because there are certain to be many nucleotide differences between sequences which are not functionally involved in the determination of phenotypic differences (Ohno, 1972 ; Kimura, 1983 ; Zuckerkandl, 1992) . A method to reduce the number of nucleotide differences to those most likely to be responsible for a phenotypic difference is needed.
The bottom-up approach involves measuring genetic variation (e.g. R F L P markers or DNA sequences) and studying its association with phenotypic variation in samples representative of the frequency distribution of the trait in a particular population of inference (reviewed by Cooper & Clayton, 1988; Lusis, 1988; Fisher et al. 1989) . Haplotypes that associate with significantly different trait levels would then be candidates for sequence comparison studies to find the functional interindividual DNA sequence variation(s). Unfortunately, results from published single locus genotype-phenotype association studies have been largely inconclusive due to the inconsistency of results among the samples studied (Cooper & Clayton, 1988 Schull & Hanis, 1990; Haviland et al. 1991 ; Zerba & Sing, 1993) . Although single locus genotype-phenotype association studies have proved useful in confirming the involvement of candidate genes in the determination of CAD risk factor trait levels (Kessling et al. 1992) , the inferences that can be drawn from these studies about genetic architecture are limited.
Since R F L P sites are common in the genome, many investigators type more than one R F L P in a region and carry out a series of single RFLP-phenotype association studies. RFLPphenotype association studies that compare results of multiple single R F L P analyses to decide which RFLP is closest to the functional interindividual DNA sequence variation are inappropriate for two reasons. First, this approach inappropriately assumes that the R F L P sites are statistically independent, i.e. the R F L P sites are in linkage equilibria. Secondly, in short regions, there is a lack of correlation between the level of disequilibrium and the distance between loci (e.g. Rather than do a series of single RFLP-phenotype association studies, multiple R F L P haplotypes have been constructed for genotype-phenotype association studies (e.g. Aquadro et al. 1992) . But, as the number of markers increases and the number of individuals in each genotype class decreases, the statistical power to detect significant phenotypic differences among haplotypes decreases. This decreased statistical power becomes critical in the study of quantitative traits because it is expected that the majority of the effects contributing to the genetic architecture of a quantitative trait will be small (Tanksley, 1993; Haviland et al. submitted) . Also, because each individual has a unique genomic sequence, there is the potential for the number of possible haplotypes t o be greater than the number of individuals in the sample or even in the population being studied. Even with modest numbers of R F L P markers, the number of pairwise comparisons among haplotypes needed to identify which haplotypes are associated with significant phenotypic differences may exceed the number of available degrees of freedom (Templeton et al. 1987) . To solve these problems, Templeton et al. developed the theory for a cladistic analysis of the association between haplotype variation and phenotype variation (Templeton et al. 1987 (Templeton et al. , 1992 Sing et al. 1992; Haviland, 1993; Templeton & Sing, 1993) . This approach uses the available degrees of freedom to test only those contrasts that have the highest probability of calling attention t o haplotypes that differ for functional interindividual sequence variation(s).
A cladistic analysis of the apo AI-CIII-AIV gene cluster will be described here. The apolipoproteins, apo AI, apo CIII and apo AIL', are known to be involved in lipoprotein metabolism and many genotype-phenotype association studies have established that variations in the genes coding for these apolipoproteins are associated with interindividual variation in plasma lipid, lipoprotein and apolipoprotein traits (reviewed by Breslow, 1988 
METHODS

Cladistic analysis
The cladistic analysis has been described fully elsewhere (Templeton et al. 1987 (Templeton et al. , 1992 Sing et al. 1992; Haviland, 1993; Templeton & Sing, 1993) and is only briefly summarized here. Two steps are involved. In the first step an unrooted cladogram, i.e. network, is built by organizing the haplotypes such that the mutational steps, hypothesized to reflect the evolutionary history that produced the current array of haplotypes, are displayed. The method of maximum parsimony was used to estimate the cladogram (Felsenstein, 1983; Sober, 1983; Stewart, 1993 ). The gene cladogram is then used to define a statistical design with which to analyse the association between haplotype variation and phenotype variation.
In the second step, instead of executing an analysis which considers all possible pairwise comparisons between haplotypes, a nested testing scheme is defined by the cladogram structure. The nesting starts by defining each unique haplotype as a O-step clade, where step refers to single mutational changes that result in the gain or loss of a restriction cut site or the creation of the insertion/deletion polymorphism. One-step clades are defined by starting at terminal haplotypes (i.e. ones that are connected t o only one other haplotype) and moving in one step. Two-step, and higher, clades are defined analogously. The phenotypic values of a trait are then compared among individuals who are grouped according to haplotype relationships defined by the cladogram. Haplotypes that have few R F L P differences, i.e. are near each other in the cladogram, but are associated with statistically significant phenotypic differences, are those hypothesized to differ for functional DNA sequence variations. The functional DNA sequence variations will most likely not be the RFLP markers used to define the haplotypes.
Sample, lipid, lipoprotein and apolipoprotein determination and RFLP typing
The sample consisted of 167 individuals of French Canadian (FC) ancestry drawn from a larger sample of healthy unrelated white-collar workers at Hydro-Quebec, a utility company in Montreal, Canada. This larger sample has been described elsewhere (Haviland P t al. et al. 1992) . The a priori exclusion criteria used to define the healthy sample were: age below 20 or above 59 years, known hypertension, diabetes, glucose intolerance, hyperlipidemia, gross obesity (body mass index > 30 kg/m2), nonfasting state, or the taking of regular, or recent, prescription or non-prescription medication (except women taking contraceptive or replacement hormones). An a posteriori exclusion procedure was also used, including the following criteria : hyperuricemia, hyperglycemia. abnormal liver function tests, urea or electrolytes, non-FC ancestry, missing results, known S.D. from the sample mean. To determine ancestry, the sampled individuals were asked whether they knew of any ancestor of theirs who was not FC and to list the surnames and maiden names of their grandparents. 167 individuals were successfully typed for six R F L P loci in the apo AI-CIII-AIV gene cluster. This sample has five fewer individuals than the one described in Haviland et al. (1991) because one individual was removed due to missing plasma lipoprotein data and four individuals were removed during a subsequent verification of the RFLP typings (see below).
Plasma levels of total cholesterol, LDL-C, apo B, VLDL-C, apo AI, HDL-C, triglycerides and lipoprotein (a) (Lp(a)) were determined as described elsewhere (Xhignesse et al. 1991 ; Kessling et al. 1992) . DNA extraction, digestion, blotting, hybridization, and autoradiography have also been described elsewhere (Kessling et al. 1992) . Two probes were used. Taken 5' to 3', they were a 2.2 kb PstI genomic fragment (Kessling et al. 1985) , which was used to detect the XmnI (Kessling et al. 1985; Coleman et al. 1986; Kessling et al. 1988b ), TaqI (Cohen et al. 1986 ), PstI (Kessling et al. 1985) and SstI RFLP loci (Rees et al. 1983) , and 1.05 kb (Kessling et al. 1988c ), a genomic probe which was used to detect the PvuII RFLP (Oettgen et al. 1986 ). Fig. 1 depicts the location of the six RFLP sites in relation to the apolipoprotein genes. In this paper, 0 and 1 denote uncut and cut RFLP alleles (insert and no insert) respectively.
The RFLP data used in this paper were collected and checked in a multistage process. At the time that the RFLP loci were originally typed, data exclusion occurred when three investigators independently reading the autoradiographs did not agree on the typing of an individual's genotype. Typings were repeated when DNA was present in sufficient amounts. At a latter stage, RFLP typings were checked again in four individuals who carried a rare haplotype (seen only once in the sample) and 24 individuals for whom haplotypes could not be determined unambiguously because they were heterozygous at two or more RFLP sites. The SstI and PstI RFLP loci were retyped using a PCR based assay (A. Minnich, personal communication), and the other RFLP loci were checked by re-reading the blots from the original analyses. Due to this data verification, four individuals were removed from the analysis because the original typings could not be confirmed.
The genotype frequencies based on the 147 individuals for whom haplotypes could be determined unambiguously (i.e. they were heterozygous a t no more than one RFLP site) are given in Table 1 . As shown in the Table, the majority of the sample for whom haplotypes could be unambiguously determined carried at least one copy of a specific haplotype designated haplotype 6. The cladistic analysis of the apo AI-CIII-AIV gene cluster presented in this paper includes only those individuals for whom haplotypes could be determined unambiguously and who carried a t least one copy of haplotype 6 ( n = 140). In other words, only one allele for the apo AI-CIII-AIV gene cluster varied among individuals, the other allele was invariant. Thus, the genotypes could be analysed as if they were haploid and a parametric statistical test could be used to test for differences among individuals grouped according to haplotype relationships (Haviland, 1993) .
Statistical analysis
All analyses were done using the SAS statistical package (SAS Institute Inc. 1989). To guard against type I1 errors, which were likely given that the size of the association between haplotype and trait variation was expected to be small, statistical tests that gave p-values equal to or less than 010 were considered significant. The results of the statistical tests are reported using two significance levels, marginally significant 005 d p < 0.10 and significant p d 005. All analyses were done separately in females and males. Those traits, VLDL-C, triglycerides and Lp(a), that were not normally distributed (results not shown) were transformed with the natural logarithm to reduce skewness. The means and variances for the concomitants and plasma lipid, lipoprotein and apolipoprotein traits were estimated. Homogeneity of variance between the genders was tested using the F-test and the means were tested for homogeneity using the t-test (Sokal & Rohlf, 1981). Satterthwaite's t-test correction was used if the variances were significantly heterogeneous between the genders. The plasma lipid, lipoprotein and apolipoprotein levels were adjusted separately in females and males by multiple polynomial regression for the concomitants : age, height, and weight to the third power, smoking and, in females, hormone use (Neter et al. 1985) . The residuals were used in a one-way analysis of variance. Then single degree of freedom contrasts, defined by the cladogram, were made to detect statistically significant associations between haplotype variation and variation in adjusted plasma lipid, lipoprotein and apolipoprotein levels. Tests of the assumption of homogeneity of variance between the pairs of haplotypes contrasted in the analysis of variance were not statistically significant (results not shown).
RESULTS
The means and standard deviations for the concomitants and plasma lipid, lipoprotein and apolipoprotein levels for females and males are given in Table 2 . The females were significantly younger, shorter and weighed less than the males. The mean plasma lipid, lipoprotein and apolipoprotein levels were significantly different between females and males for all traits except Lp(a). HDL-C and apo A1 levels were higher in females than males while the rest of the plasma lipid, lipoprotein and apolipoprotein levels were lower. The variances for weight, apo B and 1nVLDL-C were significantly smaller in females than males. The variances of total cholesterol, LDL-C and HDL-C were also heterogeneous at a less stringent level of statistical significance ( p < 0.10). These results confirm that the distributions of the concomitants and plasma lipid, lipoprotein and apolipoprotein traits were different in females and males and therefore the cladistic analysis was carried out separately by gender.
The maximum parsimony cladogram using only those haplotypes observed in haplotype 6 homo-( n = 74) and heterozygotes ( n = 66) is given in Fig. 2 . Each connection in the cladogram occurred between haplotypes differing for a single RFLP marker and defined a contrast between individuals heterozygous for haplotype 6 and individuals homozygous for haplotype 6. With seven haplotypes there are 21 possible pairwise contrasts. By using the cladogram, six evolutionarily relevant contrasts were selected representing exactly the number of degrees of Results of the cladistic analysis on adjusted plasma lipid levels in females and males. The profiles give the differences in the adjusted plasma lipid, lipoprotein and apolipoprotein levels between H 6 heterozygotes and H6 homozygotes for those genotypes that had at least one statistically significant contrast. * Denotes marginally significant differences, 005 < p < 010, and * denotes significant differences, p < 005.
freedom when there are seven haplotypes. Thus, the mean values estimated for each of the six different types of heterozygotes carrying haplotype 6 were compared with the mean of those homozygous for haplotype 6. Before testing these contrasts, the traits were adjusted separately in females and males for variability in age, height, and weight to the third power, smoking and, in females, hormone use. The means and standard deviations for the concomitants and the adjusted plasma lipid, lipoprotein and apolipoprotein levels by gender are given for each genotype in Appendix I. The one-way analysis of variance and single degree of freedom contrasts are presented in Appendix 11. The profile of mean differences for those haplotypes, in genotypes with haplotype 6, that had at least one statistically significant difference in adjusted plasma lipid, lipoprotein or apolipoprotein levels relative to haplotype 6 homozygotes are depicted in Fig. 3 .
Using the cladogram to define a priori tests, there were statistically significant contrasts between specific genotypes. Haplotypes 1 , 7 and 10, when in genotypes with haplotype 6, were associated with significant differences in adjusted levels of a t least one plasma lipid, lipoprotein or apolipoprotein trait in each gender when contrasted with haplotype 6 homozygotes. As depicted in Fig. 3 , the 1/6 genotype was significantly different from 6/6 homozygotes in the level of adjusted HDL-C levels in females; the 1/6 heterozygotes had average HDL-C levels 9.87 mg/dl higher than those observed in 6/6 homozygotes ( p < 002). Also, the females with the 7/6 genotype had average adjusted apo A1 levels 17*96mg/dl lower than the 6/6 homozygotes and this difference was marginally significant ( p < 0.07). In males, haplotypes 1 , 7 and 10, when in genotypes with haplotype 6, were associated with significantly higher adjusted apo B, LDL-C and total cholesterol levels relative to haplotype 6 homozygotes and these differences are also depicted in Fig. 3 . Males with the 10/6 genotype had average adjusted lipid, lipoprotein and apolipoprotein levels higher than 6/6 homozygotes by 37.93 mg/dl for total cholesterol levels ( p < 0.03), 35-77 mg/dl for LDL-C levels ( p < 0.01), and 36.72 mg/dl for apo B levels ( p < 0.02). The total cholesterol, LDL-C and apo B contrasts between males with the 7/6 and 6/6 genotypes were marginally significant; males with the 7/6 genotype had 22-79 mg/dl higher average adjusted total cholesterol levels ( p < O l O ) , 22-36 mg/dl higher average adjusted LDL-C levels ( p < 0.06) and 23-84 mg/dl higher average adjusted apo B levels ( p < 0.06) than 6/6 homozygotes. The average adjusted LDL-C and apo B levels in 1/6 males were also marginally higher than those in 6/6 males, by 16.94 mg/dl ( p < 0.08) and 18.07 mg/dl ( p < 007) respectively. Because certain plasma lipid, lipoprotein and apolipoprotein levels are positively correlated, for example total cholesterol, LDL-C and apo B, it was not unexpected that they were similarly associated with haplotype variation. Thus, using only those individuals for whom haplotypes could be determined unambiguously and who carried at least one copy of haplotype 6, haplotypes with gender specific effects on correlated lipid, lipoprotein and apolipoprotein levels were identified.
DISCUSSION
The analysis reported here is part of an ongoing study of a sample of healthy French Canadians (Haviland et al. 1991 Kessling et al. 1992 ). In a previous study, Kessling et al. (1992) established that the apo AI-CIII-AIV gene region should be considered as a contributor to the genetic architecture of lipid, lipoprotein and apolipoprotein traits, rather than just a candidate gene region. In the present study, using a subset of the sample, the aim was to identify haplotypes hypothesized to differ for functional DNA sequence variations within the apo AI-CIII-AIV gene cluster that influence variation in plasma lipid, lipoprotein and apolipoprotein traits. The majority of individuals in this sample carried at least one copy of a specific haplotype, designated haplotype 6. This haplotype frequency structure made it possible to carry out a haploid cladistic analysis to address the question : does variation in the other haplotype, carried by haplotype 6 heterozygotes, associate with variation in plasma lipid, lipoprotein and apolipoprotein traits.
The cladogram estimated using the haplotypes present in this sample was consistent with many of the hypotheses from coalescent theory concerning the evolution of a gene region in a species (Crandall & Templeton, 1993) . For example, coalescent theory suggests that interior haplotypes (those with more than one connection to other haplotypes) should be more frequent than tip haplotypes. This is supported by the estimated cladogram for the apo AI-CIII-AIV region in which the most frequent haplotype, haplotype 6, was interior and the other haplotypes were all tips. Also, coalescent theory suggests that the most frequent haplotype should have the most connections. Again, the apo AI-CIII-AIV cladogram supports this hypothesis because haplotype 6, the most frequent haplotype, was connected to six other haplotypes while all the other haplotypes were connected to only one. Thus, haplotype 6 is most likely the oldest haplotype and the other haplotypes descendants of it.
The traditional analysis, using the one-way analysis of variance, did not detect an association between haplotype variation and adjusted plasma lipid trait variation in this sample. Rut, by using the estimated cladogram to define an a priori hypothesis testing scheme, the average adjusted plasma lipid, lipoprotein and apolipoprotein levels of three heterozygote classes, 1 /6, 7/6 and 10/6, were found to differ from those of the 6/6 homozygotes. In females, haplotypes 1 and 7 were associated with variation in the adjusted levels of HDL-C and apo AI, although 1/6 females had on average high HDL-C levels while 7/6 females had on average low apo A1 levels, as compared to 6/6 homozygotes. In males, haplotypes 1 , 7 and 10, when in genotypes with haplotype 6, associated with elevated average adjusted total cholesterol, LDL-C and apo H levels as compared to 6/6 homozygotes. This study cannot distinguish between the possibilities that female and male inferences differed because different functional interindividual DNA sequence variations were acting in the genders, because the same functional interindividual DNA sequence variations had differing effects in the genders, or because of type I sampling errors. Assuming that the latter is not the case, it is unlikely that the interindividual DNA sequence variations acting in females and males were different because two different functional interindividual DNA sequence variations would have to be associated with the three haplotypes, each acting in only one gender. Rather, we hypothesize that the same functional interindividual DNA sequence variations were acting, but the effects of these variations differed between the genders and hence were context dependent.
It was not unexpected that the plasma lipid, lipoprotein and apolipoprotein traits associated with haplotype variation were different in females and males. The distributions of plasma lipid, lipoprotein and apolipoprotein traits in females and males have been shown to be quite different, suggesting that the underlying biology may also be different (e.g. al. 1994 ). These gender differences may be due, in part, to the association between variation in sex hormone levels and variation in lipid, lipoprotein and apolipoprotein trait levels (Kim & Kalkhoff, 1979; Gorbach et al. 1989 ) and/or variation in sex hormone levels leading to differential regulation of the genes involved in lipid metabolism (e.g. Archer et al. 1986 ). Thus, it is reasonable to hypothesize that the same functional interindividual DKA sequence variations in the apo AI-CIII-AIV gene cluster were acting in females and males in the study reported here but interactions with different modifying factors associated with gender resulted in different penetrance functions.
Many association studies, using single RFLP loci in the apo AI-CIII-AIV gene cluster a8 the measure of genetic variation, have found associations with variation in plasma lipid, lipoprotein and apolipoprotein levels (reviewed by Humphries et al. 1987; Humphries, 1988; Lusis, 1988; Boerwinkle & Hixson, 1990) . Most studies, of males only or males and females analysed separately, have found associations between variation in the apo AI-CIII-AIV gene cluster and variation in HDL-C and apo A1 levels (Kessling et al. 1988b; Paulweber et al. 1988; Wile et al. 1989; Jeenah et al. 1990; Kessling et al. 1992 ). However, the exact R F L P in association with the differing plasma lipid levels was not the same in all studies (Haviland et al. 1991 ). I t is generally hypothesized that the interindividual DNA sequence variation(s) responsible for the association with plasma apo A1 and HDL-C levels is located in the apo A1 gene. However, until the functional interindividual DNA sequence variation(s) have been identified, the hypothesis that the responsible sequences are located in or around the apo CIII and AIV genes, or in regulatory sequences within or to either side of the cluster, must also be considered.
The association between haplotype variation in the apo AI-CIII-AIV gene cluster with variation in HDL-C and apo A1 levels was only observed in females in this cladistic analysis; in males the association was found with variation in apo B, LDL-C and total cholesterol levels.
Only two previous analyses found associations between apo AI-CIII-AIV genetic variability and variation in LDL-C levels in males (Kessling et al. 1988a; Aalto-Setala et al. 1991) . The association of variation in the apo AI-CIII-AIV gene cluster with variation in many different lipid, lipoprotein and apolipoprotein traits is expected given that lipid metabolism is a complex coherent system of interacting agents (Sing & , Reilly, 1993) .
Within males, the effect of the three haplotypes identified by the cladistic analysis were similar, but it is unclear whether the functional interindividual DNA sequence variation(s) detected were the same in all three haplotypes or different. It is tempting to hypothesize that the three haplotypes had a common ancestor carrying 'the ' functional interindividual DNA sequence variation(s) and the three haplotypes diverged from it, a t other sites, over time. This hypothesis is similar to Weiss's characterization of the evolution of functional alleles as a fractal process (Weiss, 1993) . Under this characterization, a new mutation will evolve into a clade of descendent alleles, each clonal for the mutation. The alleles in this clade continue to evolve as other mutations accumulate. I n this way, evolution generates a fractal structure of alleles and allele effects. I n contrast to this hypothesis of a common ancestral DNA sequence variation, it may be that the functional interindividual DNA sequence variations in the haplotypes arose independently and probably at different sites. Of course, the answer will not be definitive until the functional DNA sequence variations have been identified.
A cladistic analysis can be used to generate hypotheses about which haplotypes should be compared to have the greatest chance of finding candidate DNA sequences responsible for the observed phenotypic effects. In the apo AI-CIII-AIV region, this analysis suggests that haplotypes 1, 7 and 10 should be compared to haplotype 6 because they are hypothesized to differ for one or more functional interindividual DNA sequence variation(s) but are similar for a large part of the gene region. A cladistic analysis can also be used to generate hypotheses about which haplotypes are unlikely to differ for functional DNA sequence variations. From this analysis there is no evidence to suggest that haplotypes 3, 5 and 8 differ from haplotype 6 a t a functional sequence variation and thus, it is unlikely that the DNA sequence variations that differentiate them have a functional effect on plasma lipid, lipoprotein or apolipoprotein levels.
An iterative cladistic approach is presently being developed aimed at identifying functional DNA sequence variations. This approach expands on the use of the cladistic approach to generate hypotheses about which haplotypes are likely or unlikely to differ for functional DNA sequence variations, and subsequently which DNA sequence variations are likely or unlikely to be functional, by applying the cladistic approach in an iterative fashion (Haviland et al. in preparation).
In summary, three haplotypes in the apo AI-CIII-AIV gene cluster were identified that, when in genotypes with haplotype 6, were associated with significant differences in adjusted plasma lipid, lipoprotein and apolipoprotein levels relative to haplotype 6 homozygotes. In females, the haplotypes associated with variation in adjusted levels of HDL-C and apo AI, while in males they were associated with variation in adjusted levels of total cholesterol, LDL-C and apo B.
Thus, the study presented here suggests that interindividual DNA sequence variations in the apo AI-CIII-AIV gene region have pleiotropic effects on several measures of lipid metabolism and the nature of these effects is gender dependent. 
